Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Jiangsheng Xu; Yunhua Liu; Yujing Li; Hai Wang; Samantha Stewart; Kevin Van der Jeught; Pranay Agarwal; Yuntian Zhang; Sheng Liu; Gang Zhao; Jun Wan; Xiongbin Lu; Xiaoming He

doi:10.1038/s41565-019-0417-y

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Jiangsheng Xu, Yunhua Liu, Yujing Li, Hai Wang, Samantha Stewart, Kevin Van der Jeught, Pranay Agarwal, Yuntian Zhang, Sheng Liu, Gang Zhao, Jun Wan, Xiongbin Lu, Xiaoming He

Cancer Biology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.

Original language	English (US)
Pages (from-to)	496
Number of pages	1
Journal	Nature Nanotechnology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1038/s41565-019-0417-y
State	Published - May 1 2019

ASJC Scopus subject areas

Bioengineering
Atomic and Molecular Physics, and Optics
Biomedical Engineering
General Materials Science
Condensed Matter Physics
Electrical and Electronic Engineering

Access to Document

10.1038/s41565-019-0417-y

Cite this

Xu, J., Liu, Y., Li, Y., Wang, H., Stewart, S., Van der Jeught, K., Agarwal, P., Zhang, Y., Liu, S., Zhao, G., Wan, J., Lu, X., & He, X. (2019). Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6). Nature Nanotechnology, 14(5), 496. https://doi.org/10.1038/s41565-019-0417-y

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6). / Xu, Jiangsheng; Liu, Yunhua; Li, Yujing et al.
In: Nature Nanotechnology, Vol. 14, No. 5, 01.05.2019, p. 496.

Research output: Contribution to journal › Comment/debate › peer-review

Xu, J, Liu, Y, Li, Y, Wang, H, Stewart, S, Van der Jeught, K, Agarwal, P, Zhang, Y, Liu, S, Zhao, G, Wan, J, Lu, X & He, X 2019, 'Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)', Nature Nanotechnology, vol. 14, no. 5, pp. 496. https://doi.org/10.1038/s41565-019-0417-y

@article{b87ab89201b646bb835132a3cc5dc4cb,

title = "Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)",

abstract = "The Supplementary Information originally published with this Article was an older version, in which {\textquoteleft}IFN-γ{\textquoteright} was misspelled {\textquoteleft}INF-γ{\textquoteright} in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.",

author = "Jiangsheng Xu and Yunhua Liu and Yujing Li and Hai Wang and Samantha Stewart and {Van der Jeught}, Kevin and Pranay Agarwal and Yuntian Zhang and Sheng Liu and Gang Zhao and Jun Wan and Xiongbin Lu and Xiaoming He",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Limited.",

year = "2019",

month = may,

day = "1",

doi = "10.1038/s41565-019-0417-y",

language = "English (US)",

volume = "14",

pages = "496",

journal = "Nature Nanotechnology",

issn = "1748-3387",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Publisher Correction

T2 - Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

AU - Xu, Jiangsheng

AU - Liu, Yunhua

AU - Li, Yujing

AU - Wang, Hai

AU - Stewart, Samantha

AU - Van der Jeught, Kevin

AU - Agarwal, Pranay

AU - Zhang, Yuntian

AU - Liu, Sheng

AU - Zhao, Gang

AU - Wan, Jun

AU - Lu, Xiongbin

AU - He, Xiaoming

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.

AB - The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.

UR - http://www.scopus.com/inward/record.url?scp=85062595915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062595915&partnerID=8YFLogxK

U2 - 10.1038/s41565-019-0417-y

DO - 10.1038/s41565-019-0417-y

M3 - Comment/debate

C2 - 30837690

AN - SCOPUS:85062595915

SN - 1748-3387

VL - 14

SP - 496

JO - Nature Nanotechnology

JF - Nature Nanotechnology

IS - 5

ER -

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this